5MJC BCU 24: Efficacy of Administering Preoperative Hydroxyprogesterone in Women with Operable Breast Cancer


Efficacy of Administering Preoperative Hydroxyprogesterone in Women with Operable Breast Cancer

Slides from a presentation at SABCS 2009 and transcribed comments from a recent interview with George W Sledge Jr, MD (2/15/10)

Dr Sledge is Professor of Medicine and Pathology at the Indiana University School of Medicine and Co-Director of the IUSCC Breast Cancer Research Program at Indiana University Simon Cancer Center in Indianapolis, Indiana.

Presentation discussed in this issue:

Badwe RA et al. Single injection depot progesterone prior to surgery in women with operable breast cancer: A randomized controlled trial. San Antonio Breast Cancer Symposium 2009;Abstract 72.

Go to previous Journal Club                                       Go to next Journal Club